| |
|
HCV | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 8. | Hepatitis C Virus Elimination Programs in Louisiana and Washington: Importance of Screening and Surveillance Systems |
| |
Public Health Manag Pract. 2023 Aug 18. doi: 10.1097/PHH.0000000000001808.Online ahead of print.
Andrew H Talal 1, Arpan Dharia, Shashi N Kapadia, Gia L Tyson, Susan Birch, Judy Zerzan-Thul, Donna Sullivan, Elizabeth Britton, Elaine Wethington, Christopher J Gonzalez, Mary Fliss, Brandon Mizroch, Frederic McCall, Audrey R Lloyd, Martin F Shapiro, Ricardo Franco
|
|
| |
|
|
| |
|
|
| |
| 11. | Hepatitis C Treatment Initiation Among US Medicaid Enrollees |
| |
JAMA Netw Open. 2023 Aug 1;6(8):e2327326. doi: 10.1001/jamanetworkopen.2023.27326.
Shashi N Kapadia 1 2, Hao Zhang 2, Christopher J Gonzalez 3, Bisakha Sen 4, Ricardo Franco 5, Kayla Hutchings 2, Elaine Wethington 6, Andrew Talal 7, Audrey Lloyd 5, Arpan Dharia 7, Martin Wells 8, Yuhua Bao 2, Martin F Shapiro 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 16. | The SHELTER Trial of Transplanting Hepatitis C Virus-Infected Lungs Into Uninfected Recipients |
| |
Transplant Direct. 2023 Jun 28;9(7):e1504. doi: 10.1097/TXD.0000000000001504.eCollection 2023 Jul.
Peter P Reese 1 2, Joshua M Diamond 3, David S Goldberg 4, Vishnu Potluri 1 2, Stacey Prenner 5, Emily A Blumberg 6, Vivianna M Van Deerlin 7, K Rajender Reddy 5, Heather Mentch 1, Richard Hasz 8, Ashley Woodards 9, Caren Gentile 7, Jennifer Smith 7, Christian Bermudez 10, Maria M Crespo 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 21. | Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors |
| |
Am J Gastroenterol. 2023 Jul 10. doi: 10.14309/ajg.0000000000002361. Online ahead of print.
Marcel Yibirin 1, Khalis Mustafayev 1, Jeff Hosry 1, Pooja Pundhir 1, Joseph Klingen 1, Eduardo Yepez Guevara 1, Bruno P Granwehr 1, Ahmed Kaseb 2, Aung Naing 3, Sapna Patel 4, Amishi Y Shah 5, Ferdinandos Skoulidis 6, Hussein A Tawbi 4, Lan Wang 7, Ethan Miller 7, Hao Chi Zhang 7, Amado Zurita-Saavedra 5, Harrys A Torres 1 7
|
|
| |
|
|
| |
|
|
| |
| 24. | Hepatitis C virus RNA is 5 |
| |
Nature. 2023 Jul;619(7971):811-818. doi: 10.1038/s41586-023-06301-3. Epub 2023 Jul 5.
Anna V Sherwood # 1, Lizandro R Rivera-Rangel # 2 3, Line A Ryberg 2 3, Helena S Larsen 2 3, Klara M Anker 1, Rui Costa 2 3, Cathrine B Vågbø 4, Eva Jakljevic 2 3, Long V Pham 2 3, Carlota Fernandez-Antunez 2 3, Gabriele Indrisiunaite 1, Agnieszka Podolska-Charlery 1, Julius E R Grothen 1, Nicklas W Langvad 1, Nicolas Fossat 2 3, Anna Offersgaard 2 3, Amal Al-Chaer 1, Louise Nielsen 2 3, Anna Kusnierczyk 4, Christina Sølund 5 6, Nina Weis 5 6, Judith M Gottwein 2 3, Kenn Holmbeck 2 3, Sandro Bottaro 7, Santseharay Ramirez 2 3, Jens Bukh 8 9, Troels K H Scheel 10 11 12, Jeppe Vinther 13
Nature. 2023 Jul;619(7971):811-818. doi: 10.1038/s41586-023-06301-3. Epub 2023 Jul 5.
Anna V Sherwood # 1, Lizandro R Rivera-Rangel # 2 3, Line A Ryberg 2 3, Helena S Larsen 2 3, Klara M Anker 1, Rui Costa 2 3, Cathrine B Vågbø 4, Eva Jakljevic 2 3, Long V Pham 2 3, Carlota Fernandez-Antunez 2 3, Gabriele Indrisiunaite 1, Agnieszka Podolska-Charlery
|
|
| |
| 25. | Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy-Boston, Massachusetts, 2016-2021 |
| |
Open Forum Infect Dis. 2023 Jul 5;10(7):ofad342. doi: 10.1093/ofid/ofad342.eCollection 2023 Jul.
Akash Gupta 1 2, Dina Ashour 1, Fatma M Shebl 1, Laura Platt 1 3, John J Chiosi 1 2, Sandra B Nelson 2, Kevin L Ard 2, Arthur Y Kim 2, Ingrid V Bassett 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 38. | Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection |
| |
Addict Dis. 2023 Jul-Sep;41(3):213-224.doi: 10.1080/10550887.2022.2088978. Epub 2022 Aug 3.
Olav Dalgard 1, Alain H Litwin 2, Oren Shibolet 3, Jason Grebely 4, Ronald Nahass 5, Frederick L Altice 6, Brian Conway 7, Edward J Gane 8, Anne F Luetkemeyer 9, Cheng-Yuan Peng 10, David Iser 11, Isaias Noel Gendrano 12, Michelle M Kelly 12, Barbara A Haber 12, Heather Platt 12, Amy Puenpatom 12; CO-STAR Investigators
|
|
| |
| 39. | Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response |
| |
JTCVS Open. 2023 Mar 10;14:602-614. doi: 10.1016/j.xjon.2023.02.014.eCollection 2023 Jun.
Mauricio A Villavicencio 1, Selena S Li 2, Ann Marie Leifer 2, Jenna L Gustafson 3, Asishana Osho 2, Stanley Wolfe 2, Yuval Raz 4, Jason Griffith 4, Isabel Neuringer 4, Emily Bethea 3, Thais Gift 5, Georgina Waldman 5, Todd Astor 4, Nathaniel B Langer 2, Raymond T Chung 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 43. | Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis |
| |
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):533-552.doi: 10.1016/S2468-1253(23)00018-3. Epub 2023 Mar 27.
Adelina Artenie 1, Jack Stone 2, Hannah Fraser 2, Daniel Stewart 3, Chiedozie Arum 4, Aaron G Lim 2, Anna L McNaughton 2, Adam Trickey 2, Zoe Ward 2, Daniela Abramovitz 5, Michel Alary 6, Jacquie Astemborski 7, Julie Bruneau 8, Steven J Clipman 9, Carla S Coffin 10, Sara Croxford 11, Kora DeBeck 12, Eva Emanuel 13, Kanna Hayashi 14, Joumana G Hermez 15, Daniel Low-Beer 16, Niklas Luhmann 16, Gisela Macphail 17, Lisa Maher 18, Norah E Palmateer 19, Eshan U Patel 20, Rachel Sacks-Davis 21, Wijnand Van Den Boom 22, Daniela K van Santen 23, Josephine G Walker 24, Matthew Hickman 2, Peter Vickerman 2; HIV and HCV Incidence Review Collaborative Group
Collaborators
- HIV and HCV Incidence Review Collaborative Group:
Malvina Aladashvili, Tasnim Azim, Paul Dietze, Kostyantyn Dumchev, Jennifer R Havens, Margaret Hellard, Sharon Hutchinson, Jennifer Iversen, Ali Judd, Martin Kåberg, Ann E Kurth, Shruti H Mehta, Viktor Mravcík, Maria Prins, Sunil S Solomon, Steffanie A Strathdee, Vana Sypsa, Catherine S Todd, Jorge Valencia, Ernst Wisse
|
|
| |
| 44. | Large-Scale, Primary Care-Based Hepatitis C Treatment in an Urban, Medically Underserved Patient Population |
| |
Public Health Rep. 2023 May 26;333549231170205. doi: 10.1177/00333549231170205.Online ahead of print.
Shelly-Ann Fluker 1, Rapheisha Darby 2, Kathryn McDaniel 3, Kristi Quairoli 3, Collins Mbonu 1, Sindhu Kilakkathi 1, Sarah Koumtouzoua 1, Ram Jagannathan 4, Lesley S Miller 1
|
|
| |
|
|
| |
| 46. | Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment |
| |
J Infect Dis. 2023 May 29;227(11):1274-1281. doi: 10.1093/infdis/jiac315.
Annelys Roque Gardner 1, Yifei Ma 2, Peter Bacchetti 3, Jennifer C Price 2, Mark H Kuniholm 4, Audrey L French 5, Stephen Gange 6, Adaora A Adimora 7, Howard Minkoff 8, Seble Kassaye 9, Igho Ofotokun 1, William Rosenberg 10, Andrea A Z Kovacs 11, Phyllis C Tien 2 12
|
|
| |
| 47. | Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study - a prospective single-arm intervention trial |
| |
Pilot Feasibility Stud. 2023 May 8;9(1):78. doi: 10.1186/s40814-023-01311-4.
Anmol Desai 1, Lauren O'Neal 2, Kia Reinis 1, Patrick Chang 1, Cristal Brown 3 4, Michael Stefanowicz 1 4, Audrey Kuang 1 3 4, Deepak Agrawal 3, Darlene Bhavnani 1, Tim Mercer 5 6 7
|
|
| |
|
|
| |
|
|
| |
| 50. | Development of a Patient Activation Toolkit for Hepatitis C Virus Testing |
| |
J Cancer Educ. 2023 Jun;38(3):931-939. doi: 10.1007/s13187-022-02209-0. Epub 2022 Aug 16.
Jessica Rivera Rivera 1, Lindsay N Fuzzell 2, Jennifer Garcia 2, Julie Rathwell 3 4, Edmondo J Robinson 2 5, Melody Chavez 2, Hayden Fulton 2, Ashley Whitmer 2, Ebin Mathew 2, Anna R Giuliano 3 4, Susan T Vadaparampil 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 56. | Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis |
| |
Am J Prev Med. 2023 Jun 26;S0749-3797(23)00278-7.doi: 10.1016/j.amepre.2023.06.016. Online ahead of print.
Pilar Hernandez-Con 1, Debbie L Wilson 1, Huilin Tang 1, Ikenna Unigwe 1, Munaza Riaz 2, Natalie Ourhaan 1, Xinyi Jiang 1, Hyun Jin Song 1, Amanda Joseph 1, Linda Henry 1, Robert Cook 3, Dushyantha Jayaweera 4, Haesuk Park 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 62. | Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study |
| |
Drug Alcohol Rev. 2023 May 30. doi: 10.1111/dar.13688. Online ahead of print.
Heather Valerio 1, Maryam Alavi 1, Alison D Marshall 1 2, Behzad Hajarizadeh 1, Janaki Amin 1 3, Matthew Law 1, Shane Tillakeratne 1, Jacob George 4, Louisa Degenhardt 5, Jason Grebely 1, Gail V Matthews 1, Gregory J Dore 1
|
|
| |
| 63. | Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019 |
| |
Clin Infect Dis. 2023 May 24;76(10):1793-1801. doi: 10.1093/cid/ciac981.
Katherine Ahrens 1, Michael Sharbaugh 2, Marian P Jarlenski 2, Lu Tang 3, Lindsay Allen 4, Anna E Austin 5, Andrew J Barnes 6, Marguerite E Burns 7, Sarah Clark 8, Kara Zivin 9, Aimee Mack 10, Gilbert Liu 10, Shamis Mohamoud 11, Mary Joan McDuffie 12, Lindsey Hammerslag 13, Adam J Gordon 14 15, Julie M Donohue 2; Writing Committee for Medicaid Outcomes Distributed Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 68. | Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation |
| |
2023 May 10. doi: 10.1097/QAD.0000000000003594. Online ahead of print.
Mathieu Chalouni 1 2, Adam Trickey 3, Suzanne M Ingle 3, Maria Antonia Sepuvelda 4, Juan Gonzalez 5, Andri Rauch 6, Heidi M Crane 7, M John Gill 8, Peter F Rebeiro 9, Jürgen K Rockstroh 10, Ricardo A Franco 11, Giota Touloumi 12, Didier Neau 13, Montserrat Laguno 14, Michaela Rappold 15 16, Colette Smit 17, Jonathan Ac Sterne 3, Linda Wittkop 1 2 18; Antiretroviral Therapy Cohort Collaboration (ART-CC)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 77. | Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs |
| |
Drug Alcohol Depend. 2023 Jun 1;247:109878.doi: 10.1016/j.drugalcdep.2023.109878. Epub 2023 Apr 17.
Judith I Tsui 1, Paula J Lum 2, Lynn E Taylor 3, Shruti H Mehta 4, Judith Feinberg 5, Arthur Y Kim 6, Brianna L Norton 7, Jiajing Niu 8, Moonseong Heo 8, Julia Arnsten 7, Irene Pericot-Valverde 9, Aurielle Thomas 10, Kendra L Blalock 11, Andrea Radick 11, Cristina Murray-Krezan 12, Kimberly Page 13, Alain H Litwin 14; HERO Study Group
|
|
| |
| 78. | The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis |
| |
J Viral Hepat. 2023 May;30(5):448-454. doi: 10.1111/jvh.13814.Epub 2023 Mar 2.
Ira M Jacobson 1, Stefan Bourgeois 2, Phillipe Mathurin 3, Paul Thuluvath 4, Stephen D Ryder 5, Guido Gerken 6, Candido Hernandez 7, Kim Vanstraelen 7, Stacey Scherbakovsky 8, Anu Osinusi 8, Dana Tedesco 8, Graham R Foster 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 84. | Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis |
| |
Hepatology. 2023 Apr 1;77(4):1348-1365. doi: 10.1002/hep.32731. Epub 2022 Sep 16.
Dimitri Loureiro 1 2, Issam Tout 1 2, Stéphanie Narguet 1 2, Cheikh Mohamed Bed 1 2, Morgane Roinard 1 2, Ahmad Sleiman 1 2, Nathalie Boyer 1 2, Nathalie Pons-Kerjean 3, Corinne Castelnau 1 2, Nathalie Giuly 1 2, Dorothy Tonui 1 2, Vassili Soumelis 4 5, Jamel El Benna 1, Patrick Soussan 6, Richard Moreau 1 2, Valérie Paradis 1 2, Abdellah Mansouri 1 2, Tarik Asselah 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 91. | Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis |
| |
Cancer Med. 2023 Apr 20. doi: 10.1002/cam4.5711. Online ahead of print.
Chiara Rocha 1, Erin H Doyle 2, Chip A Bowman 3, M-Isabel Fiel 4, Ashley E Stueck 5, Nicolas Goossens 6, Kian Bichoupan 7, James F Crismale 7, Jasnit Makkar 8, Sara Lewis 9, Ponni V Perumalswami 10, Thomas D Schiano 7, Yujin Hoshida 11, Myron Schwartz 12, Andrea D Branch 7, Neal Patel 13
|
|
| |
| 92. | Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis |
| |
Cancer Med. 2023 Apr 20. doi: 10.1002/cam4.5711. Online ahead of print.
Chiara Rocha 1, Erin H Doyle 2, Chip A Bowman 3, M-Isabel Fiel 4, Ashley E Stueck 5, Nicolas Goossens 6, Kian Bichoupan 7, James F Crismale 7, Jasnit Makkar 8, Sara Lewis 9, Ponni V Perumalswami 10, Thomas D Schiano 7, Yujin Hoshida 11, Myron Schwartz 12, Andrea D Branch 7, Neal Patel 13
|
|
| |
|
|
| |
|
|
| |
| 95. | Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study |
| |
Life (Basel). 2023 Apr 17;13(4):1033. doi: 10.3390/life13041033.
Samir Kamat 1, Sankeerth Kondapalli 2, Shumayl Syed 1, Gabrielle Price 1, George Danias 1, Ksenia Gorbenko 1 3, Joel Cantor 4, Pamela Valera 5 6, Aakash K Shah 7, Matthew J Akiyama 8
|
|
| |
| 96. | Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis |
| |
Hepatol Commun. 2023 Mar 17;7(4):e0082.doi: 10.1097/HC9.0000000000000082. eCollection 2023 Apr 1.
Lakshmi Manoharan 1, Ned H Latham 1, Stephanie C Munari 1, Michael W Traeger 1 2, Vinay Menon 1, Niklas Luhmann 3, Rachel Baggaley 3, Virginia Macdonald 3, Annette Verster 3, Nandi Siegfried 4, Gail V Matthews 5, Mark Stoové 1 2, Margaret E Hellard 1 2 6 7, Joseph S Doyle 1 2 6
|
|
| |
|
|
| |
|
|
| |
| 99. | Elimination of hepatitis C virus in a prison: An 18-year experience |
| |
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr 26;S2529-993X(23)00128-4.doi: 10.1016/j.eimce.2023.04.015. Online ahead of print.
Maite Nogales-Garcia 1, Naiara Parraza Diez 2, Andoni Vargas Axpe 3, Rafael Velasco Garcia 3, Ane Larrabeiti-Etxebarria 4, Ignacio Roy Lopez-Cano 3, Inmaculada Atrio Alvarez 3, Asier Lopez de Arcaute Trincado 3, Eva María Fernandez Lopez de Vicuña 1, Ester Saez de Adana Arroniz 4, Carlos Martínez Martínez 4, Joseba Portu Zapirain 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 105. | Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK |
| |
Liver Int. 2023 Apr;43(4):917-927. doi: 10.1111/liv.15528. Epub 2023 Feb 20.
Victoria Hamill 1 2, Will Gelson 3, Douglas MacDonald 4, Paul Richardson 5, Stephen D Ryder 6, Mark Aldersley 7, Stuart McPherson 8, Sumita Verma 9 10, Rohini Sharma 11, Sharon Hutchinson 1 2, Jennifer Benselin 6, Eleanor Barnes 12, Indra Neil Guha 6 13, William L Irving 6, Hamish Innes 1 2 14
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 109. | Spontaneous Clearance of Vertically Acquired Hepatitis C Infection: Implications for Testing and Treatment |
| |
Clin Infect Dis. 2023 Mar 4;76(5):913-991. doi: 10.1093/cid/ciac255.
A E Ades 1, Fabiana Gordon 1, Karen Scott 2, Intira Jeannie Collins 2, Claire Thorne 3, Lucy Pembrey 4, Elizabeth Chappell 2, Eugènia Mariné-Barjoan 5, Karina Butler 6, Giuseppe Indolfi 7, Diana M Gibb 2, Ali Judd 2
|
|
| |
| 110. | Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy |
| |
J Virus Erad. 2023 Mar 2;9(1):100319. doi: 10.1016/j.jve.2023.100319. eCollection 2023 Mar.
M Schwarz 1 2 3, C Schwarz 1 2 3, A Schütz 4, C Schwanke 4, E Krabb 4, R Schubert 4, S-T Liebich 4, D Bauer 1 2 3, L Burghart 1 2 3, L Brinkmann 1 2 3, E Gutic 1, T Reiberger 2 3, H Haltmayer 4, M Gschwantler 1 5
|
|
| |
| 111. | Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study |
| |
J Viral Hepat. 2023 May;30(5):397-405. doi: 10.1111/jvh.13807. Epub 2023 Feb 13.
Norah A Terrault 1 2, Jennifer Slepin 1, Rachel Kanner 1, Keri Gailloux 1, Lisa Catalli 1, Jeff McKinney 1, Stephanie Straley 1, Portia Morris 3, Rebecca Hluhanich 4, Alicia Gonzalez-Flores 5, Jennifer Dodge 2 6, Souvik Sarkar 7 8
|
|
| |
|
|
| |
|
|
| |
| 114. | Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track? |
| |
Open Forum Infect Dis. 2023 Mar 22;10(4):ofad153. doi: 10.1093/ofid/ofad153.eCollection 2023 Apr.
Jaskaran S Cheema 1, William C Mathews 1, Adriane Wynn 1, Laura B Bamford 1, Francesca J Torriani 1, Lucas A Hill 1, Amutha V Rajagopal 1, Jeffrey Yin 1, Sonia Jain 2, Richard S Garfein 1, Edward R Cachay 1, Natasha K Martin 1 3
|
|
| |
|
|
| |
| 116. | Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission |
| |
Clin Infect Dis. 2023 Mar 4;76(5):905-912. doi: 10.1093/cid/ciac270.
Anthony E Ades 1, Fabiana Gordon 1, Karen Scott 2, Intira J Collins 2, Thorne Claire 3, Lucy Pembrey 4, Elizabeth Chappell 2, Eugènia Mariné-Barjoan 5, Karina Butler 6, Giuseppe Indolfi 7, Diana M Gibb 2, Ali Judd 2
|
|
| |
| 117. | Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antivirals |
| |
J Viral Hepat. 2023 Mar 5. doi: 10.1111/jvh.13826. Online ahead of print.
Ranya Selim 1, Stuart C Gordon 1 2, Yueren Zhou 3, Talan Zhang 4, Mei Lu 4, Yihe G Daida 5, Joseph A Boscarino 6, Mark A Schmidt 7, Sheri Trudeau 4, Loralee B Rupp 8, Humberto C Gonzalez 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 126. | Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility |
| |
Med J Aust. 2023 Mar 14. doi: 10.5694/mja2.51885. Online ahead of print.
Michael B MacIsaac 1 2, Bradley Whitton 1, Adrian Hubble 1, Shelley Cogger 3, Matthew Penn 3, Anthony Weeks 3, Kasey Elmore 3, David Pemberton 3, Jenine Anderson 3, Rebecca Howard 1, Una McKeever 1, Timothy Papaluca 1 2, Margaret E Hellard 4 5 6, Mark Stoove 4 5, David Wilson 4, Alisa Pedrana 4 5, Joseph Doyle 4 6, Nico Clark 3 7, Jacinta Holmes 1 2, Alexander J Thompson 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 130. | Global reporting of progress towards elimination of hepatitis B and hepatitis C |
| |
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):332-342. doi: 10.1016/S2468-1253(22)00386-7.Epub 2023 Feb 8.
Fuqiang Cui 1, Sarah Blach 2, Casimir Manzengo Mingiedi 3, Monica Alonso Gonzalez 4, Ahmed Sabry Alaama 5, Antons Mozalevskis 6, Nicole Séguy 6, Bharat Bhushan Rewari 7, Po-Lin Chan 8, Linh-Vi Le 8, Meg Doherty 9, Niklas Luhmann 9, Philippa Easterbrook 9, Mae Dirac 10, Catherine de Martel 11, Shevanthi Nayagam 12, Timothy B Hallett 12, Peter Vickerman 13, Homie Razavi 2, Olufunmiayo Lesi 9, Daniel Low-Beer 14
|
|
| |
|
|
| |
| 132. | Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study) |
| |
Clin Infect Dis. 2023 Feb 8;76(3):e607-e612. doi: 10.1093/cid/ciac680.
Malte B Monin 1 2, Patrick Ingiliz 3, Thomas Lutz 4, Stefan Scholten 5, Christiane Cordes 6, Maria Martínez-Rebollar 7, Christoph D Spinner 8, Mark Nelson 9, Michael Rausch 10, Sanjay Bhagani 11, Lars Peters 12, Thomas Reiberger 13, Stefan Mauss 14, Jürgen K Rockstroh 1 2 15, Christoph Boesecke 1 2 15; PROBE-C study group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 137. | Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C |
| |
J Viral Hepat. 2023 Feb;30(2):129-137. doi: 10.1111/jvh.13774. Epub 2022 Dec 8.
Zak Hyde 1, Raúl Roura 1, Danielle Signer 1, Anuj Patel 1, Jacob Cohen 1, Mustapha Saheed 1, Sherilyn Brinkley 2, Risha Irvin 2, Mark S Sulkowski 2, David L Thomas 2, Richard E Rothman 1 2, Yu-Hsiang Hsieh 1
|
|
| |
| 138. | A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019 |
| |
Euro Surveill. 2023 Feb;28(6):2200184. doi: 10.2807/1560-7917.ES.2023.28.6.2200184.
Anthony Nardone 1, Lina Nerlander 2, Erika Duffell 2, Marta Valenciano 1, Maria Buti 3, Cristina Marcos-Fosch 3, Tatjana Nemeth-Blažic 4, Odette Popovici 5, Adriana Vince 6, Petruta Violeta Filip 7, Tajana Filipec 8, Mirjana Lana Kosanovic Licina 9, Boris Luksic 10, Diana Nonkovic 11, Corina Silvia Pop 7, Fabiana Radu 7, Irina Teodorescu 12, Adriana Violeta Topan 13
|
|
| |
| 139. | Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study |
| |
Int J Drug Policy. 2023 Feb 27;114:103982. doi: 10.1016/j.drugpo.2023.103982.Online ahead of print.
Jason Grebely 1, Rosie Gilliver 2, Tony McNaughton 3, Anna Conway 4, Evan Cunningham 4, Charles Henderson 3, Brett Hadlow 2, Katrina Molloy 2, Anna Doab 2, Shane Tillakeratne 4, Lucy Pepolim 3, Mary Ellen Harrod 3, Gregory J Dore 4, Phillip Read 5
|
|
| |
|
|
| |
| 141. | How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States |
| |
Int J Drug Policy. 2023 Feb;112:103930. doi: 10.1016/j.drugpo.2022.103930. Epub 2023 Jan 13.
Suzan M Walters 1, David Frank 2, Marisa Felsher 3, Jessica Jaiswal 4, Scott Fletcher 5, Alex S Bennett 6, Samuel R Friedman 7, Lawrence J Ouellet 8, Danielle C Ompad 2, Wiley Jenkins 9, Mai T Pho 10
|
|
| |
| 142. | Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis |
| |
J Viral Hepat. 2023 Feb;30(2):160-171. doi: 10.1111/jvh.13780. Epub 2022 Dec 20.
Zoë R Greenwald 1 2, Zachary Bouck 1 2, Elizabeth McLean 2, Kate Mason 3, Bernadette Lettner 3, Jennifer Broad 3, Zoë Dodd 4, Tanner Nassau 5, Ayden I Scheim 2 5 6, Dan Werb 2 7 8
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 146. | Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH) |
| |
JHEP Rep. 2022 Oct 28;5(1):100614. doi: 10.1016/j.jhepr.2022.100614. eCollection 2023 Jan.
Fabienne Marcellin 1, Sylvie Brégigeon-Ronot 2, Clémence Ramier 1, Camelia Protopopescu 1, Camille Gilbert 3, Vincent Di Beo 1, Claudine Duvivier 4 5 6 7, Morgane Bureau-Stoltmann 1, Eric Rosenthal 1 8, Linda Wittkop 3 9, Dominique Salmon-Céron 10 11, Patrizia Carrieri 1, Philippe Sogni 11 12 13, Tangui Barré 1; ANRS CO13 HEPAVIH Study Group; Scientific Committee; Clinical Centers (ward: participating physicians); Data collection; Management, statistical analyses
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 158. | Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts |
| |
BMC Public Health. 2023 Jan 7;23(1):54. doi: 10.1186/s12889-022-14911-1.
Emma Robinson # 1 2, Christopher J Byrne # 3 4 5, James Carberry 1 2, Andrew Radley 2 6, Lewis J Beer 7, Sarah K Inglis 7, Jan Tait 1, Iain Macpherson 2, David Goldberg 8 9, Sharon J Hutchinson 8 9, Matthew Hickman 10, John F Dillon 1 2
|
|
| |
|
|
| |
|
|
| |
| 161. | The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C |
| |
Trials. 2023 Jan 27;24(1):63.doi: 10.1186/s13063-022-07018-w.
Sarah E Rowan 1 2, Jason Haukoos 3 4 5, Kevin F Kamis 2, Emily Hopkins 6 7, Stephanie Gravitz 6 7, Carolynn Lyle 6 7, Alia A Al-Tayyib 2 8, Edward M Gardner 1 2, James W Galbraith 9, Yu-Hsiang Hsieh 10, Michael S Lyons 11, Richard E Rothman 10, Douglas A E White 12, Jake R Morgan 13 14, Benjamin P Linas 14 15, Allison L Sabel 16 17, David L Wyles 1; DETECT Hep C Trials Investigators
|
|
| |
| 162. | Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States |
| |
Drug Alcohol Depend. 2022 Dec 1;241:109673. doi: 10.1016/j.drugalcdep.2022.109673.Epub 2022 Oct 22.
Po-Hung Chen 1, Karine Yenokyan 2, Anthony T Fojo 3, Heidi E Hutton 4, Catherine R Lesko 2, Mary E McCaul 4, Cui Yang 5, Edward R Cachay 6, Heidi M Crane 7, Jeffrey M Jacobson 8, H Nina Kim 7, Mari M Kitahata 7, Kenneth H Mayer 9, Richard D Moore 10, Sonia Napravnik 11, Michael Saag 12, Bryan Lau 13, Geetanjali Chander 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 169. | Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial |
| |
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1112-1127.doi: 10.1016/S2468-1253(22)00275-8.
Alain H Litwin 1, Paula J Lum 2, Lynn E Taylor 3, Shruti H Mehta 4, Judith I Tsui 5, Judith Feinberg 6, Arthur Y Kim 7, Brianna L Norton 8, Moonseong Heo 9, Julia Arnsten 8, Paul Meissner 10, Alison Karasz 11, M Diane Mckee 11, John W Ward 12, Nirah Johnson 13, Irene Pericot-Valverde 14, Linda Agyemang 8, Ellen S Stein 2, Aurielle Thomas 15, Courtney Borsuk 4, Kendra L Blalock 5, Samuel Wilkinson 16, Katherine Wagner 17, Jillian Roche 7, Cristina Murray-Krezan 18, Jessica Anderson 17, Vanessa Jacobsohn 19, Anne F Luetkemeyer 2, Oluwaseun Falade-Nwulia 20, Kimberly Page 17; HERO Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 179. | Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease |
| |
Kidney Int. 2022 Dec;102(6):1228-1237. doi: 10.1016/j.kint.2022.07.012.
Paul Martin 1, Ahmed A Awan 2, Marina C Berenguer 3, Annette Bruchfeld 4, Fabrizio Fabrizi 5, David S Goldberg 6, Jidong Jia 7, Nassim Kamar 8, Rosmawati Mohamed 9, Mário Guimarães Pessôa 10, Stanislas Pol 11, Meghan E Sise 12, Ethan M Balk 13, Craig E Gordon 14, Gaelen Adam 13, Michael Cheung 15, Amy Earley 15, Michel Jadoul 16
|
|
| |
|
|
| |
| 181. | Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus Erythematosus |
| |
New Microbiol. 2022 Dec;45(4):296-303.
Alessandra Lo Presti 1, Fulvia Ceccarelli 2, Maria Dorrucci 1, Francesca Farchi 1, Carmelo Pirone 2, Cristina Garufi 2, Catia Valdarchi 1, Francesca Romana Spinelli 2, Cristiano Alessandri 2, Paola Chionne 1, Elisabetta Madonna 1, Giulio Pisani 3, Antonio Martina 3, Matteo Simeoni 3, Roberto Bruni 1, Massimo Ciccozzi 4, Giancarlo Iaiani 5, Anna Rita Ciccaglione 1, Enea Spada 1, Fabrizio Conti 2
|
|
| |
| 182. | HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago |
| |
J Public Health (Oxf). 2022 Dec 1;44(4):891-899. doi: 10.1093/pubmed/fdab190.
Sandra Tilmon 1, A Aronsohn 2, B Boodram 3, L Canary 4, S Goel 5, T Hamlish 6, S Kemble 7, D S Lauderdale 8, J Layden 9, K Lee 1, A J Millman 4, N Nelson 4, K Ritger 10, I Rodriguez 1, N Shurupova 11, J Wolf 12, D Johnson 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 186. | Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019 |
| |
Am J Public Health. 2022 Dec 8;e1-e4. doi: 10.2105/AJPH.2022.307152. Online ahead of print.
Laura Hawks 1, Emily A Wang 1, Adeel A Butt 1, Stephen Crystal 1, D Keith McInnes 1, Vincent Lo Re 3rd 1, Emily J Cartwright 1, Lisa B Puglisi 1, Lamia Y K Haque 1, Joseph K Lim 1, Amy C Justice 1, Kathleen A McGinnis 1
|
|
| |
|
|
| |
| 188. | Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study |
| |
Clin Infect Dis. 2022 Nov 14;75(10):1809-1819. doi: 10.1093/cid/ciac246.
Joanne M Carson 1, Gregory J Dore 1, Andrew R Lloyd 1, Jason Grebely 1, Marianne Byrne 1, Evan Cunningham 1, Janaki Amin 2, Peter Vickerman 3, Natasha K Martin 4, Carla Treloar 5, Marianne Martinello 1, Gail V Matthews 1, Behzad Hajarizadeh 1; Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C) Study Group
|
|
| |
| 189. | Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use |
| |
Int J Drug Policy. 2022 Nov 13;111:103906. doi: 10.1016/j.drugpo.2022.103906.Online ahead of print.
Max Spaderna 1, Sarah Kattakuzhy 2, Sun Jung Kang 3, Nivya George 4, Phyllis Bijole 5, Emade Ebah 6, Rahwa Eyasu 6, Onyinyechi Ogbumbadiugha 6, Rachel Silk 6, Catherine Gannon 7, Ashley Davis 6, Amelia Cover 6, Britt Gayle 6, Shivakumar Narayanan 4, Maryland Pao 8, Shayamasundaran Kottilil 6, Elana Rosenthal 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 194. | Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy |
| |
Obstet Gynecol. 2022 Dec 1;140(6):997-999. doi: 10.1097/AOG.0000000000004980.Epub 2022 Nov 2.
Kate R Woodworth 1, Suzanne M Newton, Emily O Olsen, Ayzsa Tannis, Lindsey Sizemore, Heather Wingate, Lauren Orkis, Bethany Reynolds, Nicole Longcore, Nadia Thomas, Angelica Bocour, Aprielle Wills, Shin Y Kim, Lakshmi Panagiotakopoulos, Carolyn Wester, Dana Delman Meaney, Suzanne M Gilboa, Van T Tong
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 203. | Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort |
| |
Cancers (Basel). 2022 Oct 27;14(21):5280. doi: 10.3390/cancers14215280.
Ilona Argirion 1, Jalen Brown 1, Sarah Jackson 1, Ruth M Pfeiffer 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly J Yu 1, Katherine A McGlynn 1, Jessica L Petrick 3, Ligia A Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Hwai-I Yang 5 7 8 9, Mei-Hsuan Lee 7, Jill Koshiol 1
|
|
| |
|
|
| |
|
|
| |
|
| | | | | |
